Search results
ValiRx (LON:VAL) Stock Price Down 10%
ETF DAILY NEWS· 1 day agoShares of ValiRx plc (LON:VAL – Get Free Report) dropped 10% on Tuesday . The company traded as low as GBX 3.55 ($0.05) and last traded at GBX 3.60 ($0.05). Approximately 9,956,905 shares changed ...
The 10 Healthiest Low-Sugar Fruits You Can Eat
Eat This, Not That! via AOL· 6 days agoShutterstockIf you're concerned about your sugar intake, it's not without merit—after all, most Americans consume too much sugar. The average U.S....
23andMe (ME) Q4 FY24 Earnings: Revenue Beats Estimates Despite 3
Guru Focus· 16 hours agoRevenue: $64 million for Q4 FY24, exceeding analyst estimates of $55.82 million and down 31% year-over-year from $92.4 million.Annual Revenue: $219.6 million f
A genome-wide association study identifies a locus associated with knee extension strength in older...
Nature· 4 days agoA genome-wide association study on knee extension strength in 3452 persons of Japanese ancestry 60 years old and above identifies a significant association at a single locus that includes TACC2, a gene encoding a cytoskeleton-related protein.
Alpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 1 day agoHC Wainwright reissued their buy rating on shares of Alpha Tau Medical (NASDAQ:DRTS – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 17 hours agoSOUTH SAN FRANCISCO, Calif., May 23, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the fourth quarter and full year of fiscal year 2024 (
ASCO Publishes Guidelines for Germline Testing in Solid Tumors
GenomeWeb News· 4 days agoThe American Society of Clinical Oncology on Friday released guidelines to help guide use of multigene germline genetic testing panels for cancer patients. The guidelines, ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoCogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment of Cole Pinnow as ...
Q2 2024 EPS Estimates for Barinthus Biotherapeutics plc Increased by HC Wainwright (NASDAQ:BRNS)
ETF DAILY NEWS· 3 days agoBarinthus Biotherapeutics plc (NASDAQ:BRNS – Free Report) – Equities researchers at HC Wainwright raised their Q2 2024 earnings per share estimates for Barinthus Biotherapeutics in a research ...
